Regulatory management option analysis
The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.
For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.
RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Further information
Last updated 15 mars 2019. Database contains 215 unique substances/entries.
| 400-370-7 | - | Finland | Bioaccumulation Other environmental toxicity Persistence | Under development | Under development | No suggestion yet | 15/03/2019 | Details | |
| 258-649-2 | 53585-53-8 | Finland | Bioaccumulation Other environmental toxicity Persistence | Under development | Under development | No suggestion yet | 15/03/2019 | Details | |
| 225-625-8 | 4979-32-2 | Germany | Bioaccumulation Exposure Persistence Widespread use | Under development | Under development | No suggestion yet | 28/02/2019 | Details | |
| 404-360-3 | 119313-12-1 | Austria | Toxic for reproduction | Under development | Under development | No suggestion yet | 26/02/2019 | Details | |
| show/hide | - | - | Sweden | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 30/01/2019 | Details |
| 229-176-9 | 6422-86-2 | France | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 25/01/2019 | Details | |
| 206-400-3 | 335-76-2 | Germany | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 25/01/2019 | Details | |
| 201-071-2 | 77-94-1 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 22/01/2019 | Details | |
| 204-881-4 | 128-37-0 | France | Carcinogenic Endocrine disruption Exposure Skin sensitiser | Concluded | Appropriate to initiate regulatory risk management action | Other legislation | 17/01/2019 | Details | |
| 246-563-8 | 25013-16-5; 121-00-6 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 17/01/2019 | Details | |
| 214-946-9 | 1222-05-5 | France | Endocrine disruption | Under development | Under development | No suggestion yet | 21/12/2018 | Details | |
| 700-242-3 | 62037-80-3 | Netherlands | Other environmental toxicity Other human toxicity | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 21/12/2018 | Details | |
| 701-028-2 | 26523-78-4 | France | Endocrine disruption Skin sensitiser | Under development | Under development | No suggestion yet | 21/12/2018 | Details | |
| 216-036-7 | 1478-61-1 | Sweden | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | CLH | 20/12/2018 | Details | |
| 204-126-9 | 116-14-3 | Ireland | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 05/12/2018 | Details | |
| 203-772-9 | 110-49-6 | Sweden | Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 29/11/2018 | Details | |
| 272-486-4 | 68855-45-8 | Sweden | Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 28/11/2018 | Details | |
| 272-233-8 | 68784-25-8 | Sweden | Mutagenic Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 28/11/2018 | Details | |
| 272-234-3 | 68784-26-9 | Sweden | Toxic for reproduction | Concluded | No need to initiate further regulatory risk management action at this time | None | 28/11/2018 | Details | |
| show/hide | - | - | Germany | Bioaccumulation Persistence Toxic for reproduction Widespread use | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 09/11/2018 | Details |
| 204-826-4 | 127-19-5 | Commission | Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 26/10/2018 | Details | |
| 212-828-1 | 872-50-4 | Commission | Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 25/10/2018 | Details | |
| 245-152-0 | 22673-19-4 | Sweden | Toxic for reproduction | Under development | Under development | No suggestion yet | 25/10/2018 | Details | |
| 200-679-5 | 68-12-2 | Commission | Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 25/10/2018 | Details | |
| 208-169-4 | 513-79-1 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 24/10/2018 | Details | |
| 200-755-8 | 71-48-7; 6147-53-1 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 24/10/2018 | Details | |
| 231-589-4 | 7646-79-9; 7791-13-1 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 24/10/2018 | Details | |
| 233-402-1 | 10141-05-6; 10026-22-9 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 24/10/2018 | Details | |
| 233-334-2 | 10124-43-3; 10026-24-1 | ECHA | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Restriction | 24/10/2018 | Details | |
| 231-106-7 | 7439-97-6 | Denmark | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | Other | 15/10/2018 | Details | |
| 232-565-6 | 9000-90-2 | United Kingdom | Respiratory sensitiser Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | Other | 12/09/2018 | Details | |
| covering any of its individual anti- and syn-isomers or any combination thereof show/hide rel-(1R,4S,4aS,6aR,7R,10S,10aS,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene EC / List no: - | CAS no: - 1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene EC / List no: 236-948-9 | CAS no: 13560-89-9 | - | - | United Kingdom | Bioaccumulation Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 10/08/2018 | Details |
| 260-830-6 | 57583-54-7 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other | 10/08/2018 | Details | |
| 202-924-1 | 101-20-2 | France | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | Other | 10/08/2018 | Details | |
| 221-967-7 | 3296-90-0 | Norway | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH SVHC | 03/07/2018 | Details | |
| 401-720-1 | 6807-17-6 | Sweden | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 17/05/2018 | Details | |
| 203-585-2 | 108-46-3 | Finland | Endocrine disruption | Concluded | Appropriate to initiate regulatory risk management action | CLH | 17/05/2018 | Details | |
| 400-600-6 | 71868-10-5 | Austria | Toxic for reproduction | Under development | Under development | No suggestion yet | 08/05/2018 | Details | |
| 233-660-5 | 10294-40-3 | Netherlands | Carcinogenic | Under development | Under development | No suggestion yet | 13/04/2018 | Details | |
| 214-012-0 | 1072-63-5 | Sweden | Toxic for reproduction | Under development | Under development | No suggestion yet | 10/04/2018 | Details | |
| 211-765-7 | 693-98-1 | Sweden | Toxic for reproduction | Under development | Under development | No suggestion yet | 10/04/2018 | Details | |
| 205-861-8 | 156-62-7 | ECHA | Other human toxicity STOT RE Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH Restriction | 12/03/2018 | Details | |
| show/hide 1,1,2,2,3,3,4,4,4-nonafluoro-N-(2-hydroxyethyl)-N-methylbutane-1-sulphonamide EC / List no: 252-043-1 | CAS no: 34454-97-2 | - | - | Norway | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 12/03/2018 | Details |
| 223-861-6 | 4098-71-9 | Sweden | Exposure Mutagenic Skin sensitiser | Concluded | No need to initiate further regulatory risk management action at this time | None | 09/02/2018 | Details | |
| D5 | 208-764-9 | 541-02-6 | Germany | Bioaccumulation Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/01/2018 | Details |
| 234-541-0 | 12008-41-2; 12280-03-4 | Sweden | Carcinogenic Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/01/2018 | Details | |
| D6 | 208-762-8 | 540-97-6 | United Kingdom | Bioaccumulation Consumer use Exposure Persistence Widespread use | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 05/01/2018 | Details |
| D4 | 209-136-7 | 556-67-2 | Germany | Aggregated tonnage Bioaccumulation Exposure Other environmental toxicity Persistence | Concluded | Appropriate to initiate regulatory risk management action | SVHC | 05/01/2018 | Details |
| 206-196-6 | 307-24-4 | Germany | Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | SVHC Restriction | 05/01/2018 | Details | |
| 255-288-2 | 41272-40-6 | Netherlands | Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction | Concluded | Appropriate to initiate regulatory risk management action | CLH | 15/12/2017 | Details | |
Route: .live2




